Latest return on equity
ALX Oncology Holdings Return on equity
Direct answer
ALX Oncology Holdings's return on equity is -80.65%.
The verified market snapshot reports -80.65%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 19, 2026.
Get free ALX Oncology Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -80.65%
Explore related company data
View ALX Oncology Holdings's market capitalizationView ALX Oncology Holdings's price-to-book ratioView ALX Oncology Holdings's 52-week price rangeView ALX Oncology Holdings's profit marginView ALX Oncology Holdings's debt-to-equity ratioView all ALX Oncology Holdings key metricsReturn to ALX Oncology Holdings profile